KANGHUI PHARMACEUTICAL(SH:603139) Shang Hai Zheng Quan Bao·2026-01-21 19:24Core Viewpoint - The company, Shaanxi Kanghui Pharmaceutical Co., Ltd., is providing a guarantee for its subsidiary, Sichuan Chunsheng Pharmaceutical Group Co., Ltd., for a credit facility of 8 million RMB from Sichuan Tianfu Bank, which is aimed at supporting the subsidiary's operational needs [1][2]. Group 1: Guarantee Details - The company will provide a joint liability guarantee for the credit facility, covering the principal amount of 8 million RMB along with interest, penalties, and other related costs, with a guarantee period of three years from the debt maturity date [2][5]. - The subsidiary's shareholder, Mr. Luo Chunming, and Ms. Yin Nianjuan have signed a counter-guarantee agreement, assuming a counter-guarantee responsibility of 3.92 million RMB, which aligns with the company's guarantee period [2][6]. Group 2: Internal Decision-Making Process - The company’s board of directors approved the guarantee for the subsidiary during meetings held on April 27, 2025, and May 20, 2025, allowing for a total guarantee limit of 199 million RMB for the fiscal year 2025, with a specific limit of 34 million RMB for Chunsheng Pharmaceutical [3][9]. Group 3: Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary and reasonable as it aligns with the operational needs of the subsidiary and is within the approved limits by the shareholders, with the subsidiary currently having a stable operational status and no overdue debts [8][9]. Group 4: Cumulative Guarantee Situation - As of the announcement date, the total guarantee amount provided by the company for its subsidiaries is 87.03 million RMB, which represents 10.48% of the company's latest audited net assets as of the end of 2024 [11]. - If the subsidiary draws the 8 million RMB loan, the total guarantee amount will increase to 97.83 million RMB, accounting for 11.41% of the company's net assets [11].